Financials

Discussions Technicals Seasonals

4172 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

InnoPharmax, Inc. engages in the development and commercialization of pharmaceutical products for the treatment of oncology. Its product categories include anti-infection agents, contrast agents, oncology agents, immunological agents, and drugs for rare diseases. The company was founded on October 27, 2005 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

4172 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company